Brain death is defined as the irreversible loss of brain and brainstem functions, making organ harvesting legally possible. We have aimed to determine the current donation and harvesting rates in Eskisehir, Turkey to achieve further donation rates by improving the conditions. We have analyzed the data of brain death cases from Eskisehir Osmangazi University Hospital and 2 state hospitals based on a time interval between 2013 and 2017. The evaluation of 113 cases of brain death revealed that organ harvesting could be performed in 25.7% of those cases, whereas organ donation was not approved in 74.3% of those deceased patients due to refusal of the legally responsible relatives. The results of a study carried out in Bursa as the first-ranked province in the Organ Donation List of Turkey in 2012 suggested that relatives permitted organ donation in only 34.6% of 79 brain death cases between 2007 and 2014, whereas that rate was 8.8% of 4.9 cadaver donations per million persons in Bursa, Turkey. A comparison between the results of Eskisehir and a neighboring province showed that lower rates of organ donation in Eskisehir may be caused by absence of a transplantation center in the province, therefore, putting the transplantation center of the university hospital into service will accelerate the rates of organ donation in Eskisehir.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.transproceed.2019.01.188 | DOI Listing |
Pharmacol Rep
January 2025
Department of Pharmacy, The First People's Hospital of Changzhou/The Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China.
Tacrolimus (TAC) is an immunosuppressant widely utilized in organ transplantation. One of its primary adverse effects is glucose metabolism disorder, which significantly increases the risk of diabetes. Investigating the molecular mechanisms underlying TAC-induced diabetes is essential for developing effective prevention and treatment strategies for these adverse effects.
View Article and Find Full Text PDFLiver Transpl
January 2025
Hepato-biliary-pancreatic Surgery and Liver Transplantation Unit, Padua University Hospital, Padua, Italy.
Total hepatectomy and liver transplantation has emerged as a game-changing strategy in the treatment of several liver-confined primary or metastatic tumors, opening the new era of transplant oncology. However, the expansion of indications is going to worsen the chronic scarcity of organs, and new strategies are needed to enlarge the donor pool. A possible source of organs could be developing split liver transplantation (SLT) programs.
View Article and Find Full Text PDFJ Virol
January 2025
Institute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, Jilin, China.
Unlabelled: Respiratory syncytial virus (RSV) infections continue to plague infants, young children, and older individuals worldwide. Since there is no specific treatment for RSV, characterizing the interactions between RSV and host factors remains crucial for the eventual development of robust therapeutic interventions. In our previous study, guanylate binding protein 5 (GBP5) was shown to promote excessive RSV-small hydrophobic (RSV-SH) protein secretion by microvesicles and inhibited viral replication.
View Article and Find Full Text PDFJ Leukoc Biol
January 2025
Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Macrophages play a crucial role in the immune response during allograft rejection in organ transplantation. Therefore, our study aimed to explore the genomic features of macrophages in mouse heart transplants and use single-cell RNA sequencing to investigate Galectin-9 (Gal-9, Lgals9), a lectin that can mediate the activation and differentiation of immune cells through ligand-receptor interactions, and the effects of its regulation in transplantation. We discovered a new subset of macrophages called "Myoz2+ macrophages", which specifically expressed genes related to myocardial contraction.
View Article and Find Full Text PDFInt J Med Robot
February 2025
Department of Surgery, Division of Transplantation, SUNY Upstate Medical University, Syracuse, New York, USA.
Background: We aimed to investigate the outcome of patients after RDN at different time points.
Methods: We studied the outcomes of 77 living robotic living donor nephrectomies (RDN). Donors were separated into three groups: learning curve period (LCP), stabilisation period (SP), and teaching period (TP).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!